XML 45 R27.htm IDEA: XBRL DOCUMENT v3.25.0.1
Segment Reporting
6 Months Ended
Jan. 31, 2025
Segment Reporting [Abstract]  
Segment Reporting
Note 18. Segment Reporting
The Company’s reportable segments are: Mobile Solutions, Industrial Solutions and Life Sciences. The organizational structure also includes Corporate and Unallocated, which includes interest expense and certain corporate expenses determined to be non-allocable to the segments, such as restructuring charges and business development expenses. The Company determines its operating segments consistent with the manner in which it manages its operations and evaluates performance for internal review and decision-making. For the three and six months ended January 31, 2025, Corporate and Unallocated included charges of $6.6 million and $9.9 million, respectively, related primarily to restructuring and business development.
The Mobile Solutions segment is organized based on a combination of customers and products and consists of the Off-Road, On-Road and Aftermarket business units. Within these business units, products consist of replacement filters for both air and liquid filtration applications and filtration housings for new equipment production and systems related to exhaust and emissions. Applications include air filtration systems, fuel, lube and hydraulic systems, emissions systems and sensors, indicators and monitoring systems. Mobile Solutions sells to original equipment manufacturers (OEMs) in the construction, mining, agriculture and transportation end markets and to independent distributors and OEM dealer networks.
The Industrial Solutions segment is organized based on product type and consists of Industrial Air Filtration, Industrial Gases, Industrial Hydraulics, Power Generation and Aerospace and Defense products. These products are further organized by the Industrial Filtration Solutions and Aerospace and Defense business units. Within our industrial portfolio, the Company provides a wide product offering in the market to industrial customers consisting of equipment, ancillary components, replacement parts, performance monitoring and service globally, that cost-effectively enhances productivity and manufacturing efficiency. Industrial Air Filtration, Industrial Gases and Industrial Hydraulics products consist of dust, fume and mist collectors, compressed air and industrial gases purification systems, hydraulic and lubricated rotating filtration applications as well as gas and liquid filtration for industrial processes. Power Generation products consist of air inlet systems and filtration sold to gas compression, power generation and natural gas liquification industries. Aerospace and Defense products consist of air, fuel, lubrication and hydraulic filtration for fixed-wing and rotorcraft aerospace applications and ground defense vehicle and naval platforms. Industrial Solutions businesses sell through multiple channels which include OEMs, distributors and direct-to-consumer in some markets.
The Life Sciences segment is organized by end market and consists of the Bioprocessing Equipment and Consumables, Food and Beverage, Vehicle Electrification and Medical Device, Microelectronics and Disk Drive markets. Within these markets, products consist of micro-environment gas and liquid filtration for food and beverage and industrial processes, bioprocessing equipment, including bioreactors and fermenters, bioprocessing consumables including chromatography devices, reagents and filters, polytetrafluoroethylene membrane-based products, as well as specialized air and gas filtration systems for applications including hard disk drives, semiconductor manufacturing, sensors, battery systems and powertrain components. Life Sciences primarily sells to large OEMs and directly to various end users requiring cell growth, separation, purification, high purity filtration and device protection.
The Company has manufacturing facilities that serve multiple reportable segments. As such, capital expenditure information by reportable segment has not been provided because the Company does not produce or utilize such information internally. In addition, although depreciation and amortization expense is a component of each reportable segment’s operating results, it is not discretely identifiable as a result of the shared manufacturing facilities.
The Company is an integrated enterprise, characterized by substantial intersegment cooperation, cost allocations and sharing of assets. Therefore, the Company does not represent that these segments, if operated independently, would report earnings before income taxes and other financial information as stated below.
Segment details were as follows (in millions):
Three Months Ended
January 31,
Six Months Ended
January 31,
2025202420252024
Net sales
Mobile Solutions$547.5 $550.3 $1,119.9 $1,090.3 
Industrial Solutions253.7 263.4 511.3 509.6 
Life Sciences68.8 63.0 138.9 123.1 
Total Company$870.0 $876.7 $1,770.1 $1,723.0 
Earnings (loss) before income taxes
Mobile Solutions$95.5 $99.2 $200.2 $191.4 
Industrial Solutions40.9 47.4 81.9 90.7 
Life Sciences(0.5)(5.8)(5.8)(10.0)
Total segment
135.9 140.8 276.3 272.1 
Corporate and unallocated(1)
(10.9)(11.8)(20.8)(20.2)
Total Company$125.0 $129.0 $255.5 $251.9 
(1)Corporate and unallocated includes interest expense and certain corporate expenses determined to be non-allocable to the segments, such as restructuring charges and portions of incentive compensation.
Assets by segment were as follows (in millions):
January 31, 2025July 31, 2024
Mobile Solutions$1,339.7 $1,339.5 
Industrial Solutions829.8 821.7 
Life Sciences501.3 512.1 
Total segment assets
2,670.8 2,673.3 
Corporate and unallocated290.5 241.0 
Total assets$2,961.3 $2,914.3 
Net sales by business unit were as follows (in millions):
Three Months Ended
January 31,
Six Months Ended
January 31,
2025202420252024
Mobile Solutions segment
Off-Road$80.2 $91.9 $169.3 $186.6 
On-Road25.3 33.5 57.4 71.3 
Aftermarket442.0 424.9 893.2 832.4 
Total Mobile Solutions segment547.5 550.3 1,119.9 1,090.3 
Industrial Solutions segment
Industrial Filtration Solutions207.5 224.5 419.9 435.1 
Aerospace and Defense46.2 38.9 91.4 74.5 
Total Industrial Solutions segment253.7 263.4 511.3 509.6 
Life Sciences segment
Total Life Sciences segment68.8 63.0 138.9 123.1 
Total Company$870.0 $876.7 $1,770.1 $1,723.0 
Concentrations
There were no customers that accounted for over 10% of net sales for the three and six months ended January 31, 2025 or 2024. There were no customers that accounted for over 10% of gross accounts receivable as of January 31, 2025 or July 31, 2024.